
Most b2b demand generation strategies medtech founders run are demand capture. Google Ads, retargeting, and conference booths all catch buyers who already know they have the problem.
A medtech pipeline moves when a company builds category awareness first, then adds the channels that convert people who were never looking in the first place.
Key Takeaways
Watch the full episode on YouTube
A founder looks at the CRM, sees leads tagged "Google AdWords," and concludes paid search generates demand. It doesn't.
I covered this on an episode reviewing the state of medtech sales and marketing:
"There are things that are going to generate demand and things are going to capture demand. When you look at your CRM, you might notice that a lot of your leads have come from Google AdWords. That's not the thing that generated demand, that's the thing that captured demand. You have to get more sophisticated about attribution."
That distinction changes the entire budget conversation. A founder who thinks Google Ads generates demand keeps pouring money into the channel that only catches buyers who were already searching.
The market never gets bigger. It just gets split between competitors bidding on the same three keywords.
Demand generation and demand capture are sequential. Skip the first step and the second one has nothing to convert.
"When I think marketing, demand generation. Then, in an ideal world, as you generate the demand, you also need to capture it. It's almost like lobbing a baseball really high up in the air. You've got to jog over to where it's going to land and catch it."
The founders who get this backward run capture campaigns into a market that doesn't know it has a problem yet. The ads underperform.
The sales team blames marketing, and the company concludes demand generation "doesn't work for medtech." Nobody threw the ball first.
Before a founder can generate demand, the category the product competes in has to exist in the buyer's head. That takes longer than most funding runways assume.
I interviewed Bruce Cleveland on an episode about product-market fit, category design, and why startups waste funding. He's advised medtech and enterprise founders on go-to-market for two decades, and his guidance is specific:
"You need to build the category before you start doing the demand gen. You need to build thought leadership. Invest in that for 12 to 18 months."
— Bruce Cleveland (The State of MedTech)
A 12 to 18 month runway of category education reads like a luxury to a founder watching burn rate. But Cleveland's point is that skipping it doesn't save time.
It just moves the cost downstream into a demand generation campaign that has no category to sell into, which is a more expensive place to discover the gap.
The same episode makes the mechanism explicit:
"Most medtech founders don't have a demand problem. What they have is a definition problem. Until you define a market clearly, you're not able to get any traction."
— Bruce Cleveland (The State of MedTech)
This is the exact sequencing problem covered in what a go-to-market strategy misses when the market hasn't formed yet, where demand generation tactics assume a defined category. Run them before the category exists, and the tactics have nothing to attach to.
The clearest proof that digital demand generation works in medtech without a large team comes from a founder who built one in two months.
Tony Recupero, President of SI-BONE, described the campaign on an episode covering lessons from US Surgical, Kyphon, and SI-BONE:
"In 60 days, that's right, that's only two months, I was able to put 35 deals in the pipeline of a variety of different hospitals. Big hospitals such as University of Kansas, UCSF, or Cleveland Clinic. I essentially used LinkedIn and a few other digital channels and strategies."
— Tony Recupero, President of SI-BONE (The State of MedTech)
Thirty-five hospital-level deals in 60 days did not come from a Google Ads budget chasing existing search volume.
It came from a founder building visibility with the specific institutions he wanted to reach, then converting the attention once it existed. That's demand generation and demand capture run in the correct order, by one person, without a marketing department.
In my experience working with medtech founders, the ones who say demand generation "doesn't work" almost always mean they ran capture tactics into an undefined category. A bigger ad budget does not solve that.
"You can't outsell a misdefined market. Validation is repeatable pipeline creation and conversion. Don't confuse attention with demand."
Every b2b demand generation strategy that works in medtech starts with the same sequence. Define the category, build the thought leadership that makes it real to buyers, then layer in the channels that capture the demand just created.
Reverse that order and no channel mix repairs it.
For the upstream framework that makes this sequence work, see the medtech commercialization strategy and market engineering framework.
Demand generation creates awareness of a category or problem the buyer didn't know they had. Demand capture converts buyers who already know what they want into pipeline, usually through search ads, retargeting, or inbound forms.
Most medtech marketing spend goes to capture channels while founders call the results "demand generation."
Bruce Cleveland's guidance to medtech founders is 12 to 18 months of category-building and thought leadership before running full demand generation campaigns. That runway builds the market definition the campaigns need to convert against.
Skipping it doesn't save time. It just pushes the same problem into a more expensive stage.
Yes. Tony Recupero generated 35 hospital-level pipeline deals in 60 days at SI-BONE using LinkedIn and a small set of digital channels, without a marketing department. The constraint that matters is a clearly defined category to communicate.
If you're doing this yourself: The Market Engineering Audit framework starts with the same category-definition question Bruce Cleveland raises: does your market exist in the buyer's head yet, or are you about to run demand capture into a category nobody recognizes.
If you want it engineered with you: MarketCraft takes on a small number of medtech teams each quarter, starting with The Market Engineering Audit. For teams already running paid channels with flat results, the audit usually finds the category-definition gap before it finds a channel problem.
Subscribe wherever you listen to podcasts.
Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry.
He works with medtech founders and commercial leaders on market engineering, commercialization strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.